{"disease":{"id":"anti-ulcer-agents","name":"anti ulcer agents"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03383042","title":"Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of JP-1366 Oral Administration in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Jeil Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05181124","title":"Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Onconic Therapeutics Inc.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}